Correlation Between AstraZeneca PLC and Daiichi Sankyo

Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Daiichi Sankyo at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Daiichi Sankyo into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between AstraZeneca PLC and Daiichi Sankyo, you can compare the effects of market volatilities on AstraZeneca PLC and Daiichi Sankyo and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Daiichi Sankyo. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Daiichi Sankyo.

Diversification Opportunities for AstraZeneca PLC and Daiichi Sankyo

0.63

Correlation Coefficient

AstraZeneca PLC  Daiichi Sankyo

Poor diversification

The 3 months correlation between AstraZeneca and Daiichi is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC and Daiichi Sankyo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daiichi Sankyo and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC are associated (or correlated) with Daiichi Sankyo. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daiichi Sankyo has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Daiichi Sankyo go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and Daiichi Sankyo

Assuming the 90 days horizon AstraZeneca PLC is expected to under-perform the Daiichi Sankyo. But the pink sheet apears to be less risky and, when comparing its historical volatility, AstraZeneca PLC is 2.64 times less risky than Daiichi Sankyo. The pink sheet trades about -0.1 of its potential returns per unit of risk. The Daiichi Sankyo is currently generating about -0.04 of returns per unit of risk over similar time horizon. If you would invest  3,585  in Daiichi Sankyo on September 15, 2024 and sell it today you would lose (865.00) from holding Daiichi Sankyo or give up 24.13% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

AstraZeneca PLC  vs.  Daiichi Sankyo

AstraZeneca PLC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days AstraZeneca PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's fundamental indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Daiichi Sankyo

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Daiichi Sankyo has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with AstraZeneca PLC and Daiichi Sankyo

The main advantage of trading using opposite AstraZeneca PLC and Daiichi Sankyo positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Daiichi Sankyo can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daiichi Sankyo will offset losses from the drop in Daiichi Sankyo's long position.

The idea behind AstraZeneca PLC and Daiichi Sankyo pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.